Shu-Min Xiong
Impact in
- Hematology top 1%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Biochemistry top 2%
- Antioxidant Activity and Oxidative Stress
Papers in
- Hematology 12
- Acute Myeloid Leukemia Research 12
- Chronic Myeloid Leukemia Treatments 3
- Genetics 4
- Myeloproliferative Neoplasms: Diagnosis and Treatment 3
Shu-Min Xiong
22 papers receiving 2.3k citations
Hit Papers
Peers
Comparison fields: 5 of 106
- Hematology 1.0k
- Biochemistry 307
- Molecular Biology 1.7k
- Immunology 365
- Genetics 171
Countries citing papers authored by Shu-Min Xiong
This map shows the geographic impact of Shu-Min Xiong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu-Min Xiong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu-Min Xiong more than expected).
Fields of papers citing papers by Shu-Min Xiong
This network shows the impact of papers produced by Shu-Min Xiong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu-Min Xiong. The network helps show where Shu-Min Xiong may publish in the future.
Co-authors
The 25 scholars most cited alongside Shu-Min Xiong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2023 | 8 | |
| 3 | Neutrophils in cancer carcinogenesis and metastasis Hit paper breakdown → | 2021 | 343 |
| 4 | 2020 | 2 | |
| 5 | 2020 | 2 | |
| 6 | 2019 | 39 | |
| 7 | 2019 | 16 | |
| 8 | 2018 | 17 | |
| 9 | 2018 | 2 | |
| 10 | 2017 | 12 | |
| 11 | 2015 | 7 | |
| 12 | 2014 | 81 | |
| 13 | 2012 | 2 | |
| 14 | 2012 | 36 | |
| 15 | 2011 | 101 | |
| 16 | 2005 | 226 | |
| 17 | 2002 | 12 | |
| 18 | 2001 | 14 | |
| 19 | 1999 | 80 | |
| 20 | Use of Arsenic Trioxide (As2O3 ) in the Treatment of Acute Promyelocytic Leukemia (APL): II. Clinical Efficacy and Pharmacokinetics in Relapsed Patients Hit paper breakdown → | 1997 | 1181 |
About Shu-Min Xiong
Shu-Min Xiong is a scholar working on Hematology, Genetics, Emergency Medicine, Developmental Neuroscience and Biochemistry, having authored 22 papers that have together received 2.3k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (12 papers), Pluripotent Stem Cells Research (4 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers), Hematological disorders and diagnostics (3 papers), Epigenetics and DNA Methylation (3 papers), Retinoids in leukemia and cellular processes (3 papers), Chronic Myeloid Leukemia Treatments (3 papers) and Acute Lymphoblastic Leukemia research (2 papers). The work is most often cited by research in Hematology (1.0k citations), Biochemistry (307 citations), Molecular Biology (1.7k citations), Immunology (365 citations) and Genetics (171 citations). Shu-Min Xiong has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Lin Cheng, Sai‐Juan Chen, Zhixiang Shen, Guoqiang Chen, Zhenyi Wang, Zhu Chen, Guan-Lin Sun, Yu Chen, Jun Zhu and Yanting Wang. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Hematology Journal, Journal of Hematology & Oncology, Blood and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.